Skip to Main Content

Several U.K. lawmakers have asked Pfizer not to raise the price of its Covid-19 vaccine, citing concerns such a move could strain the U.K. National Health Service and public finances.

In a letter to Pfizer chief executive officer Albert Bourla, the lawmakers noted the company plans to raise the price of its shot to $110 to $130 a dose in the U.S. and they asked him to confirm during an upcoming call with Wall Street analysts and investors that Pfizer will not take the same step in the U.K.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment